Wednesday 18th November 2009 |
Text too small? |
Shareholders of Fonterra Cooperative Group, the world’s largest exporter of dairy products, voted to allow themselves to hold shares amounting to 120% of their production in the first step of a strategy to restructure the company.
Holders of 89.6% of the stock voted in favour of strengthening Fonterra’s share structure while agreeing to an effective freeze on the so-called Fair Value Share price at $4.52. Fonterra will change the way it values the shares to recognize they can’t be freely traded and will hold the price at current levels until the ‘restricted market’ price catches up.
The initial steps, approved at Fonterra’s annual meeting in Ashburton today, are a precursor to a more radical shake up, requiring a separate vote, where the shares would become tradable among shareholders.
The company would also cease redemptions of the shares, which it does now, to ensure farmers’ holdings match up with their production each year – a process that causes huge fluctuations in Fonterra’s equity capital. Current arrangements forced it to pay out $742 million in redemptions after the 2007/2008 drought.
The vote showed “great confidence in the cooperative and our future,” chairman Henry van der Heyden said in a statement after the meeting. Farmers “said give us the opportunity to back our cooperative.”
Allowing farmers to add try shares to their holding may allow Fonterra to raise as much as $900 million. It is the cooperatives second attempt at restructuring in as many years. Fonterra would have raised as much as $2.5 billion selling about a fifth of the stock in the sale it abandoned last year.
The current process is in three stages and is aimed at tackling the loss of equity value on the balance sheet as shares are redeemed when production declines.
Businesswire.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors